Research Paper Volume 16, Issue 1 pp 857—871
Treatment patterns and survival analysis in patients with unresectable stage III EGFR-mutated non-small cell lung cancer
Figure 5. Locoregional-free survival between TKI alone and TKI+chemotherapy groups. (A) The unmatched cohort. (B) The propensity score matching cohort.